Cogent Biosciences Inc (COGT) Net Income by Year
Cogent Biosciences Inc reported a net loss of $328.9M in fiscal year 2025. This represents a decrease of 28.6% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Cogent Biosciences Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
COGT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
COGT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Cogent Biosciences Inc financials
Frequently Asked Questions
What was Cogent Biosciences Inc's net income in fiscal year 2025?
Cogent Biosciences Inc reported a net loss of $328.9M in fiscal year 2025.
How fast is Cogent Biosciences Inc's net income growing?
Cogent Biosciences Inc (COGT) net income fell by 28.6% year over year, from -$255.9M to -$328.9M in fiscal year 2025.
How has Cogent Biosciences Inc's net income changed over the years?
Across the 9 fiscal years this page covers, Cogent Biosciences Inc (COGT) net income went from -$25.5M in fiscal year 2017 to -$328.9M in fiscal year 2025.
What was Cogent Biosciences Inc's net income in the most recent quarter?
Cogent Biosciences Inc (COGT) reported -$96.4M in net income in Q2 2026. This represents a decrease of 31.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Cogent Biosciences Inc (COGT) reported on that line in every period on record.